Skip to main content
SpringerLink
Log in

Parkinson-Syndrom und zerebrovaskuläre Morbidität

  • Conference paper
Der multimorbide Parkinsonpatient

  • 57 Accesses

Zusammenfassung

Sowohl bei den Parkinson-Syndromen als auch bei den meisten zerebrovaskulären Störungen handelt es sich urn alterskorrelierte Störungen mit deutlicher Zunahme von Inzidenz und Prävalenz im Senium. Besonders bei der subkortikalen arteriosklerotischen Enzephalopathie (SAE) kann es zur Ausbildung eines sogenannten „Vaskulären Parkinson-Syndroms” kommen, das gegenüber der idiopathischen Parkinsonerkrankung klinische Besonderheiten aufweist. Im Einzelfall kann diese Differenzialdiagnose jedoch erhebliche Schwierigkeiten bereiten und Probleme im therapeutischen Vorgehen aufwerfen. Wenig erforscht ist bisher die Frage, wie sich altersassoziierte mikroangiopathische Veränderungen des Gehirns auf das klinische Bild eines vorbestehenden oder koinzidierenden idiopathischen Parkinson-Syndroms auswirken.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Baezner H, Oster M, Henning O, Cohen S, Hennerici MG (2001) Amantadine increases gait steadiness in frontal gait disorder due to subcortical vascular encephalopathy: a double-blind randomized placebo-controlled trial based on quantitative gait analysis. Cerebrovasc Dis 11: 235–244

    Article  PubMed  CAS  Google Scholar 

  2. Baloh RW, Yue Q, Socotch TM, Jacobson KM (1995) White matter lesions and disequilibrium in older people. I. Case-control comparison. Arch Neurol 52: 970–974

    Article  PubMed  CAS  Google Scholar 

  3. Bonnet AM, Loria Y, Saint-Hilaire MH, Lhermitte F, Agid Y (1987) Does long-term aggravation of Parkinson’s disease result from nondopaminergic lesions? Neurology 37: 1539–1542

    Article  PubMed  CAS  Google Scholar 

  4. Critchley M (1929) Arteriosclerotic parkinsonism. Brain 52: 23–83

    Article  Google Scholar 

  5. Durif F, Pollak P, Hommel M, Ardouin C, Le Bas JF, Crouzet G, Perret J (1992) Relationship between levodopa-independent symptoms and central atrophy evaluated by magnetic resonance imaging in Parkinson’s disease. Eur Neurol 32: 32–36

    Article  PubMed  CAS  Google Scholar 

  6. Fitzgerald PM, Jankovic J (1989) Lower body parkinsonism: evidence for vascular etiology. Mov Disord 4: 249–260

    Article  PubMed  CAS  Google Scholar 

  7. Ebersbach G, Sojer M, Müller J, Ransmayr G, Wenning G, Poewe W (2002) Gleichgewichtsstörungen bei idiopathischer Parkinson-Erkrankung. Der Einfluss zerebrovaskulärer Komorbidität. Nervenarzt 73: 162–165

    Article  PubMed  CAS  Google Scholar 

  8. Ebersbach G et al. (1999) Comparative analysis of gait in Parkinson’s disease, cerebellar ataxia and subcortical arteriosclerotic encephalopathy. Brain 122: 1349–1355

    Article  PubMed  Google Scholar 

  9. Hughes AJ, Daniel SE Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study. J Neurol Neurosurg Psychiatry 55: 181–184

    Article  PubMed  CAS  Google Scholar 

  10. Kannus P, Parkkari J, Niemi S, Pasanen M, Palvanen M, Jarvinen M, Vuori I (2000) Prevention of hip fracture in elderly people with use of a hip protector. N Engl J Med 343: 1562–1563

    Article  Google Scholar 

  11. Liston R, Tallis RC (2000) Gait apraxia and multi-infarct states. In: Meara J, Koller WC (eds) Parkinson’s disease in the elderly. University Press, Cambridge, pp 98–110

    Google Scholar 

  12. Marie P (1901) Des foyers lacunaires de désintegration et de differents autres etats cavitaires du cerveau. Rev Med 21: 281–298

    Google Scholar 

  13. Masdeu JC, Wolfson L, Lantos G, Tobin JN, Grober E, Whipple R, Amerman P (1989) Brain white-matter changes in the elderly prone to falling. Arch Neurol 46: 1292–1296

    Article  PubMed  CAS  Google Scholar 

  14. Meyer JS, Barron DW (1960) Apraxia of gait: a clinicopathological study. Brain 83: 261–284

    Article  Google Scholar 

  15. Nutt JG, Marsden CD, Thompson PD (1993) Human walking and higher-level gait disorders, particularly in the elderly. Neurology 43: 268–279

    Article  PubMed  CAS  Google Scholar 

  16. Piccini P, Pavese N, Canapicchi R et al. (1996) White matter hyperintensities in Parkinson’s disease. Clinical correlations. Arch Neurol 52: 191–194

    Article  Google Scholar 

  17. Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ (1987) Psychotropic drug use and the risk of hip fracture. N Engl J Med 316: 363–369

    Article  PubMed  CAS  Google Scholar 

  18. de Rijk MC, Tzourio C, Breteler MM et al. (1997) Prevalence of parkinsonism and Parkinson’s disease in Europe: the EUROPARKINSON Collaborative Study. J Neurol Neurosurg Psychiatry 62: 10–15

    Article  PubMed  Google Scholar 

  19. Sudarsky L (1990) Gait disorders in the elderly. N Engl J Med 322: 1441–1446

    Article  PubMed  CAS  Google Scholar 

  20. Thompson PD, Marsden CD (1987) Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger’s disease. Mov Disord 2: 1–8

    Article  PubMed  CAS  Google Scholar 

  21. Winikates J, Jankovic J (1994) Vascular progressive supranuclear palsy. J Neural Transm Suppl 43: 189–201

    Article  Google Scholar 

  22. Winikates J, Jankovic J (1999) Clinical correlates of vascular parkinsonism. Arch Neurol 56: 98–102

    Article  PubMed  CAS  Google Scholar 

  23. van Zagten M, Lodder J, Kessels F (1998) Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions. Mov Disord 13: 89–95

    Article  PubMed  Google Scholar 

Download references

Authors
  1. G. Ebersbach
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Neurologische Klinik der Ruhr-Universität Bochum, St. Josef-Hospital, Gudrunstraße 56, 44791, Bochum, Germany

    Horst Przuntek  & Thomas Müller  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Ebersbach, G. (2002). Parkinson-Syndrom und zerebrovaskuläre Morbidität. In: Przuntek, H., Müller, T. (eds) Der multimorbide Parkinsonpatient. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57512-9_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57512-9_6

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-7985-1353-2

  • Online ISBN: 978-3-642-57512-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation